Mesenchymal stem cells in regenerative medicine: a new paradigm for degenerative bone diseases

In this Regenerative Medicine Editorial, learn why it is imperative to delineate a deeper and more critical understanding of the physiology of mesenchymal stem cells, including their survival time, ability to home into organs and tissues and donor-to-donor variability.

Go to the profile of Regenerative Medicine
May 09, 2017
Upvote 0 Comment

A functional characteristic of mesenchymal stem cells (MSCs) is their ability to differentiate into ectoderm, mesoderm and endoderm tissues including bone, neurons, muscles, hepatocytes, skin, among others. Nowadays, MSCs are valuable sources of therapeutics for regenerative medicine. In this Editorial, published in Regenerative Medicine, the authors explore how MSCs could be utilized in the treatment of degenerative bone diseases.

Shyam H, Singh SK, Kant R, Saxena SK. Mesenchymal stem cells in regenerative medicine: a new paradigm for degenerative bone diseases. Regen. Med. 12(2), 111–114 (2017)

Author for correspondence:

Go to the profile of Regenerative Medicine

Regenerative Medicine

Journal, Future Science Group

Regenerative Medicine is an award-winning peer-reviewed journal, in print and web formats. The journal provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats. Among other indexing services Regenerative Medicine is listed by MEDLINE/Index Medicus, EMBASE/Excerpta Medica, Chemical Abstracts, Science Citation Index Expanded™ (SciSearch®), Emcare, Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index®, Journal Citation Reports/Science Edition®, Scopus® with an Impact Factor of 2.786 (2014). Each issue contains expertly drafted Reviews, Original Research articles, Perspectives, Editorials, topical insight from international leaders in their field, and additional added-value content. The Senior Editor of the journal is Professor Chris Mason, University College London. You can find out more about Regenerative Medicine at our website (, where you can find the aims and scope of the journal and details of our international editorial board.

No comments yet.